MPN | Age 46 | New Dx

I’m working up a patient for erythrocytosis. His BMBx was mildly hypocellular at 20-40% for a 46yo (heavy EtOH use) and cytogenetics and myeloid NGS panel were normal and without mutations respectively. Do you think his EtOH could be masking the expected panmyelosis of PV?

Lung Cancer | Age 70 | New Dx

70 y/o with met. NSCLC developed colitis on maintenance pembro. Excellent response to steroids but colitis recurs after taper. Got restarted on steroids and now starting on infliximab. Do you continue the steroids or stop/ taper them?

Multiple Myeloma | Age 58

58M with IgG lambda MM, R-ISS 1, standard risk cytogenetics. Recently, developed localized prostate cancer. Would you stop revlimid maintenance in setting of another cancer?

Lymphoma | Oncology Pharmacist

65 year-old patient with stage III Hodgkin's is having a tough time with Bren-AVD. I'm thinking patient will need dose reductions or delays. Any ideas on how to manage side effects?

AML | Age 67 | R/R

Recurrent AML patient with complex karyotype and hepatitic C cirrhosis. Negative for FLT3 and IDH mutations. Started Venclexta plus Vidaza. What is your experience with cirrhotic patients and this regimen?

Hematology | Age 61

Male age 61 sent to me for macrocytic anemia. Started him on folic acid and plan to start steroids for AIHA. Do you agree with that and adding rituxan only if that fails?